Close

Optimer Pharma (OPTR) Said to Draw Interest from Glaxo (GSK), Astellas

Go back to Optimer Pharma (OPTR) Said to Draw Interest from Glaxo (GSK), Astellas

Cantor Fitzgerald Downgrades Cubist Pharmaceuticals (CBST) to Sell; Doesn't See Deal for Optimer (OPTR)

April 3, 2013 7:48 AM EDT

Cantor Fitzgerald downgraded Cubist Pharmaceuticals (NASDAQ: CBST) from Hold to Sell but raised its price target from $38 to $40 saying an Optimer (NASDAQ: OPTR) deal is unlikely.

Analyst Adeyemi Ogunkoya notes that Cubist traded up in tandem with Optimer after the company announced on Feb... More